Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Scott I. Kahan, MD, MPH. Practical Strategies for Engaging Individuals With Obesity in Primary Care. Mayo Clin Proc. 2018;93 ...

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least one related health condition. The once-weekly injectable supports weight loss ...

The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

A significant advancement in weight management has arrived for Singaporeans. Danish pharma Novo Nordisk has announced the ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

Biocon aims to introduce generic versions of the obesity drug Wegovy in India and Canada by late 2026 or early 2027, ...

The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & ...